Cairo – Mubasher: The public offering of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) has been oversubscribed by 36.28 times on the last day of subscription, informed sources told Mubasher on Wednesday.
Investors placed 1,816 buy orders for 683.2 million shares, according to the sources.
Meanwhile, the company’s private offering was oversubscribed by 117%, CI Capital, the lead manager for the transaction, revealed.
On 28 November, Rameda launched its public offering that includes 18.8 million shares at EGP 4.66 per share.
